Finally, inhibition of another FLT3 downstream pathway [8,45,49], the PI3K-Akt signaling pathway, reverses resistance of T-ALL [52] and MLL-ALL [19] cells to GCs. Here, KMT2A is linked to acute lymphoblastic leukemia.